Musso M - Search Results

1

Phase III comparative trial using CHOP vs CIOP in the treatment of advanced intermediate-grade non-Hodgkin's lymphoma.

Zinzani PL, Martelli M, Storti S, Musso M, Cantonetti M, Leone G, Cajozzo A, Papa G, Iannitto E, Perrotti A, et al. Zinzani PL, et al. Among authors: musso m. Leuk Lymphoma. 1995 Oct;19(3-4):329-35. doi: 10.3109/10428199509107906. Leuk Lymphoma. 1995. PMID: 8535227 Clinical Trial.

2

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage.

Ladetto M, De Marco F, Benedetti F, Vitolo U, Patti C, Rambaldi A, Pulsoni A, Musso M, Liberati AM, Olivieri A, Gallamini A, Pogliani E, Rota Scalabrini D, Callea V, Di Raimondo F, Pavone V, Tucci A, Cortelazzo S, Levis A, Boccadoro M, Majolino I, Pileri A, Gianni AM, Passera R, Corradini P, Tarella C; Gruppo Italiano Trapianto di Midollo Osseo (GITMO); Intergruppo Italiano Linfomi (IIL). Ladetto M, et al. Among authors: musso m. Blood. 2008 Apr 15;111(8):4004-13. doi: 10.1182/blood-2007-10-116749. Epub 2008 Jan 31. Blood. 2008. PMID: 18239086 Free article. Clinical Trial.

3

Comparative activity of idarubicin and idarubicinol in combination with cyclosporin A in multidrug-resistant leukemia cells.

Tolomeo M, Gancitano RA, Musso M, Porretto F, Perricone R, Abbadessa V, Cajozzo A. Tolomeo M, et al. Among authors: musso m. Cancer Chemother Pharmacol. 1996;39(1-2):157-61. doi: 10.1007/s002800050552. Cancer Chemother Pharmacol. 1996. PMID: 8995514

4

Successful treatment of resistant thrombotic thrombocytopenic purpura/hemolytic uremic syndrome with autologous peripheral blood stem and progenitor (CD34+) cell transplantation.

Musso M, Porretto F, Crescimanno A, Bondì F, Polizzi V, Scalone R, Iannitto E, Mariani G. Musso M, et al. Bone Marrow Transplant. 1999 Jul;24(2):207-9. doi: 10.1038/sj.bmt.1701859. Bone Marrow Transplant. 1999. PMID: 10455352

5

Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party.

Castagnetti F, Palandri F, Amabile M, Testoni N, Luatti S, Soverini S, Iacobucci I, Breccia M, Rege Cambrin G, Stagno F, Specchia G, Galieni P, Iuliano F, Pane F, Saglio G, Alimena G, Martinelli G, Baccarani M, Rosti G; GIMEMA CML Working Party. Castagnetti F, et al. Blood. 2009 Apr 9;113(15):3428-34. doi: 10.1182/blood-2007-08-103499. Epub 2009 Feb 11. Blood. 2009. PMID: 19211938 Free article. Clinical Trial.

6

[Potentiation of the antiblastic activity of mafosfamide by GM-CSF and interleukin-3: a possible use in the treatment of acute myeloblastic leukemia].

Tolomeo M, Luparello M, Caravello E, Musso M, Abbadessa V, Perricone R, Cajozzo A. Tolomeo M, et al. Among authors: musso m. Ann Ital Med Int. 1990 Oct-Dec;5(4 Pt 1):341-7. Ann Ital Med Int. 1990. PMID: 2093359 Italian.

7

[Effect of buflomedil on the behavior of platelet aggregation and its clinical evaluation in elderly patients with chronic cerebrovascular insufficiency].

Cajozzo A, Abbadessa V, Musso M, Iannitto E. Cajozzo A, et al. Among authors: musso m. Minerva Med. 1983 Jul 14;74(28-29):1727-31. Minerva Med. 1983. PMID: 6346139 Clinical Trial. Italian.

8

Therapy of acute myelogenous leukemia in adults.

Petti MC, Broccia G, Caronia F, Di Raimondo F, Fioritoni G, Ladogana S, Leone G, Liso V, Musso M, Neri A, et al. Petti MC, et al. Among authors: musso m. Haematol Blood Transfus. 1990;33:249-53. doi: 10.1007/978-3-642-74643-7_45. Haematol Blood Transfus. 1990. PMID: 2182417 Clinical Trial. No abstract available.

9

Intrapleural adriamycin in treatment of myelomatous pleural effusion: a case report.

Iannitto E, Scaglione R, Musso M, Abbadessa V, Licata G. Iannitto E, et al. Among authors: musso m. Haematologica. 1988 Jul-Aug;73(4):325-6. Haematologica. 1988. PMID: 3139537 No abstract available.

10

Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease.

Went P, Ascani S, Strøm E, Brorson SH, Musso M, Zinzani PL, Falini B, Dirnhofer S, Pileri S. Went P, et al. Among authors: musso m. Lancet Oncol. 2004 Jun;5(6):381-3. doi: 10.1016/S1470-2045(04)01495-0. Lancet Oncol. 2004. PMID: 15172359 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters